{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:06:10Z","timestamp":1787238370181,"version":"build-2736575974"},"reference-count":96,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:p>Heightened publicity about hormonal contraception and thrombosis risk and the publication of new guidelines by the World Health Organization in 2009 and the Centers for Disease Control and Prevention in 2010 addressing this complex issue have led to multidisciplinary discussions on the special issues of adolescents cared for at our pediatric hospital. In this review of the literature and new guidelines, we have outlined our approach to the complex patients referred to our center. The relative risk of thrombosis on combined oral contraception is three- to fivefold, whereas the absolute risk for a healthy adolescent on this therapy is only 0.05% per year. This thrombotic risk is affected by estrogen dose, type of progestin, mechanism of delivery, and length of therapy. Oral progestin-only contraceptives and transdermal estradiol used for hormone replacement carry minimal or no thrombotic risk. Transdermal, vaginal, or intrauterine contraceptives and injectable progestins need further study. A personal history of thrombosis, persistent or inherited thrombophilia, and numerous lifestyle choices also influence thrombotic risk. In this summary of one hospital's approach to hormone therapies and thrombosis risk, we review relative-risk data and discuss the application of absolute risk to individual patient counseling. We outline our approach to challenging patients with a history of thrombosis, known thrombophilia, current anticoagulation, or family history of thrombosis or thrombophilia. Our multidisciplinary group has found that knowledge of the guidelines and individualized management plans have been particularly useful for informing discussions about hormonal and nonhormonal options across varied indications.<\/jats:p>","DOI":"10.1542\/peds.2010-2221","type":"journal-article","created":{"date-parts":[[2011,1,3]],"date-time":"2011-01-03T22:43:25Z","timestamp":1294094605000},"page":"347-357","source":"Crossref","is-referenced-by-count":101,"title":["Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach"],"prefix":"10.1542","volume":"127","author":[{"suffix":"III","given":"Cameron C.","family":"Trenor","sequence":"first","affiliation":[{"name":"Divisions of Hematology\/Oncology,"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Chung","sequence":"additional","affiliation":[{"name":"Adolescent\/Young Adult Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Michelson","sequence":"additional","affiliation":[{"name":"Divisions of Hematology\/Oncology,"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis J.","family":"Neufeld","sequence":"additional","affiliation":[{"name":"Divisions of Hematology\/Oncology,"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Adolescent\/Young Adult Medicine,"},{"name":"Endocrinology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Laufer","sequence":"additional","affiliation":[{"name":"Adolescent\/Young Adult Medicine,"},{"name":"Gynecology, Departments of Medicine and Surgery, Children's Hospital Boston, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Jean","family":"Emans","sequence":"additional","affiliation":[{"name":"Adolescent\/Young Adult Medicine,"},{"name":"Gynecology, Departments of Medicine and Surgery, Children's Hospital Boston, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"issue":"29","key":"2021121007073520400_B1","first-page":"1","article-title":"Use of contraception in the United States: 1982\u20132008","author":"Mosher","year":"2010","journal-title":"Vital Health Stat 23"},{"issue":"2","key":"2021121007073520400_B2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1963.03060020091034","article-title":"Oral contraception and venous thrombosis","volume":"185","author":"Tyler","year":"1963","journal-title":"JAMA"},{"issue":"8990","key":"2021121007073520400_B3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"2021121007073520400_B4","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"2021121007073520400_B5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"issue":"8990","key":"2021121007073520400_B6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"issue":"7259","key":"2021121007073520400_B7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.321.7259.477","article-title":"Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database","volume":"321","author":"Farmer","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"2021121007073520400_B8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of Ortho Evra and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"2021121007073520400_B9","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"2021121007073520400_B10","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"2021121007073520400_B11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humupd\/5.6.672","article-title":"Biological coagulation findings in third-generation oral contraceptives","volume":"5","author":"Conard","year":"1999","journal-title":"Hum Reprod Update"},{"issue":"9","key":"2021121007073520400_B12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2021121007073520400_B13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2005.01335.x","article-title":"Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide","volume":"3","author":"Deguchi","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2021121007073520400_B14","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1538-7836.2010.03930.x","article-title":"17\u03b1-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor \u03b1","volume":"8","author":"Cleuren","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2021121007073520400_B15","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jcem.86.8.7768","article-title":"Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women","volume":"86","author":"Luyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"8935","key":"2021121007073520400_B16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"2021121007073520400_B17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"2021121007073520400_B18","volume-title":"Pediatric and Adolescent Gynecology","author":"Emans","year":"2005"},{"issue":"5","key":"2021121007073520400_B19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"2021121007073520400_B20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2021121007073520400_B21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2009.12.014","article-title":"Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation \u201cpill scare\u201d","volume":"81","author":"Heinemann","year":"2010","journal-title":"Contraception"},{"issue":"2 pt 1","key":"2021121007073520400_B22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users [published correction appears in Obstet Gynecol. 2008;111(6):1449]","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121007073520400_B23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"2021121007073520400_B24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"2021121007073520400_B25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"Ortho Evra and venous thromboembolism: an update","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"5","key":"2021121007073520400_B26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"2021121007073520400_B27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2008.07.004","article-title":"Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis","volume":"78","author":"Jensen","year":"2008","journal-title":"Contraception"},{"key":"2021121007073520400_B28","article-title":"The risk of venous thrombosis associated with non-oral hormonal contraceptives","author":"van Hylckama Vlieg"},{"issue":"7083","key":"2021121007073520400_B29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: population based case-control study","volume":"314","author":"P\u00e9rez Gutthann","year":"1997","journal-title":"BMJ"},{"issue":"13","key":"2021121007073520400_B30","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"2021121007073520400_B31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2021121007073520400_B32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"7655","key":"2021121007073520400_B33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"issue":"6475","key":"2021121007073520400_B34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"1","key":"2021121007073520400_B35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/1096-8652(200009)65:1<45::AID-AJH8>3.0.CO;2-V","article-title":"The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese","volume":"65","author":"Irani-Hakime","year":"2000","journal-title":"Am J Hematol"},{"issue":"10","key":"2021121007073520400_B36","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"18","key":"2021121007073520400_B37","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1016\/S0021-9258(18)42309-5","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: resolution of the antithrombin conformational change contribution to heparin rate enhancement","volume":"267","author":"Olson","year":"1992","journal-title":"J Biol Chem"},{"issue":"5","key":"2021121007073520400_B38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.moh.0000239712.93662.35","article-title":"The endothelial protein C receptor","volume":"13","author":"Esmon","year":"2006","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2021121007073520400_B39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2021121007073520400_B40","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2021121007073520400_B41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/jmg.40.8.619","article-title":"Geographical and ethnic variation of the 677C&gt;T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide","volume":"40","author":"Wilcken","year":"2003","journal-title":"J Med Genet"},{"issue":"5","key":"2021121007073520400_B42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.167.5.497","article-title":"No association between the common MTHFR 677C-&gt;T polymorphism and venous thrombosis: results from the MEGA study","volume":"167","author":"Bezemer","year":"2007","journal-title":"Arch Intern Med"},{"issue":"15","key":"2021121007073520400_B43","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"issue":"15","key":"2021121007073520400_B44","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121007073520400_B45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2021121007073520400_B46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-146-11-200706050-00157","article-title":"Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial","volume":"146","author":"Ray","year":"2007","journal-title":"Ann Intern Med"},{"issue":"10","key":"2021121007073520400_B47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6","key":"2021121007073520400_B48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"issue":"3","key":"2021121007073520400_B49","first-page":"800","article-title":"Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia","volume":"86","author":"Martinelli","year":"2001","journal-title":"Thromb Haemost"},{"issue":"2","key":"2021121007073520400_B50","first-page":"1","article-title":"Pregnancy-related mortality surveillance: United States, 1991\u20131999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"7","key":"2021121007073520400_B51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","article-title":"The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism","volume":"21","author":"Spencer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"2021121007073520400_B52","volume-title":"WHO Research Into Global Hazards of Travel (WRIGHT) Project: Final Report of Phase I","author":"World Health Organization","year":"2007"},{"issue":"1","key":"2021121007073520400_B53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2005-863810","article-title":"Travel, venous thromboembolism, and thrombophilia","volume":"31","author":"Gallus","year":"2005","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2021121007073520400_B54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1538-7836.2010.03819.x","article-title":"Explanations for coagulation activation after air travel","volume":"8","author":"Schreijer","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2021121007073520400_B55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-151-3-200908040-00129","article-title":"Meta-analysis: travel and risk for venous thromboembolism","volume":"151","author":"Chandra","year":"2009","journal-title":"Ann Intern Med"},{"key":"2021121007073520400_B56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/CCM.0b013e3181c9cbd9","article-title":"Thrombotic risk factors: basic pathophysiology","volume":"38","author":"Martinelli","year":"2010","journal-title":"Crit Care Med"},{"issue":"8","key":"2021121007073520400_B57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archsurg.1997.01430320064010","article-title":"Timing of the occurrence of pulmonary embolism in trauma patients","volume":"132","author":"Owings","year":"1997","journal-title":"Arch Surg"},{"issue":"7","key":"2021121007073520400_B58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MBC.0b013e3283079e58","article-title":"Risk factors for venous thromboembolism in the elderly: results of the master registry","volume":"19","author":"Ageno","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"2021121007073520400_B59","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"issue":"2","key":"2021121007073520400_B60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"2021121007073520400_B61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21059","article-title":"Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use","volume":"83","author":"Pomp","year":"2008","journal-title":"Am J Hematol"},{"key":"2021121007073520400_B62","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/COC.0b013e3181b01b17","article-title":"The link between cancer and venous thromboembolism: a review","volume":"32","author":"Kessler","year":"2009","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"2021121007073520400_B63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0029-1242716","article-title":"Thrombosis in systemic lupus erythematosus","volume":"35","author":"Palatinus","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"2021121007073520400_B64","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2009"},{"key":"2021121007073520400_B65","unstructured":"Faculty of Sexual & Reproductive Healthcare. UK medical eligibility criteria for contraceptive use. Available at: www.ffprhc.org.uk\/admin\/uploads\/UKMEC2009.pdf. Accessed November 22, 2010"},{"issue":"1","key":"2021121007073520400_B66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG practice bulletin No. 110: noncontraceptive uses of hormonal contraceptives","volume":"115","author":"American College of Obstetricians and Gynecologists","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2021121007073520400_B67","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"American College of Obstetricians and Gynecologists","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"RR-4","key":"2021121007073520400_B68","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use","volume":"59","author":"Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion; Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"2021121007073520400_B69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.2009.07820.x","article-title":"Testing children for inherited thrombophilia: more questions than answers","volume":"147","author":"Raffini","year":"2009","journal-title":"Br J Haematol"},{"issue":"2","key":"2021121007073520400_B70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2021121007073520400_B71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"issue":"7","key":"2021121007073520400_B72","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","article-title":"Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users","volume":"83","author":"Samuelsson","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2021121007073520400_B73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2005.10.029","article-title":"Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS): a systematic enquiry and overview","volume":"125","author":"Varma","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2021121007073520400_B74","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121007073520400_B75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"2021121007073520400_B76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jpag.2008.11.003","article-title":"The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population","volume":"22","author":"Doyle","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"2021121007073520400_B77","first-page":"921","article-title":"ACOG committee opinion: number 310, April 2005\u2014endometriosis in adolescents","volume":"105","author":"American College of Obstetricians and Gynecologists","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2021121007073520400_B78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jmig.2006.06.008","article-title":"The role of progestins in treating the pain of endometriosis","volume":"13","author":"Surrey","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"2021121007073520400_B79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.contraception.2008.07.017","article-title":"Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis\u2014a pilot study","volume":"79","author":"Walch","year":"2009","journal-title":"Contraception"},{"key":"2021121007073520400_B80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1196\/annals.1429.012","article-title":"Hormone replacement therapy for the adolescent patient","volume":"1135","author":"DiVasta","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2021121007073520400_B81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1083-3188(02)00145-6","article-title":"The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa","volume":"15","author":"Golden","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"2021121007073520400_B82","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jadohealth.2006.09.010","article-title":"Effects of an oral contraceptive (norgestimate\/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study","volume":"39","author":"Strokosch","year":"2006","journal-title":"J Adolesc Health"},{"issue":"4","key":"2021121007073520400_B83","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00198-007-0518-6","article-title":"Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature","volume":"19","author":"Vescovi","year":"2008","journal-title":"Osteoporos Int"},{"issue":"10","key":"2021121007073520400_B84","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1249\/mss.0b013e318149f111","article-title":"American College of Sports Medicine position stand: the female athlete triad","volume":"39","author":"Nattiv","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"2021121007073520400_B85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-141602401-9.10014-8","article-title":"Thrombophilia: Clinical and laboratory assessment and management","volume-title":"Consultative Hemostasis and Thrombosis","author":"Heit","year":"2007","edition":"2nd ed."},{"issue":"6","key":"2021121007073520400_B86","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"issue":"3","key":"2021121007073520400_B87","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2021121007073520400_B88","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2796.2007.01867.x","article-title":"Travel and venous thrombosis: a systematic review","volume":"262","author":"Kuipers","year":"2007","journal-title":"J Intern Med"},{"issue":"22","key":"2021121007073520400_B89","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/archinte.163.22.2771","article-title":"Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives","volume":"163","author":"Martinelli","year":"2003","journal-title":"Arch Intern Med"},{"issue":"24","key":"2021121007073520400_B90","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121007073520400_B91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinternmed.2007.5","article-title":"Minor injuries as a risk factor for venous thrombosis","volume":"168","author":"van Stralen","year":"2008","journal-title":"Arch Intern Med"},{"issue":"6519","key":"2021121007073520400_B92","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"12","key":"2021121007073520400_B93","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1445-1433.2004.03258.x","article-title":"Evidence-based risk factors for postoperative deep vein thrombosis","volume":"74","author":"Edmonds","year":"2004","journal-title":"ANZ J Surg"},{"issue":"3","key":"2021121007073520400_B94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"issue":"6","key":"2021121007073520400_B95","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2021121007073520400_B96","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.1997.03540320044033","article-title":"A prospective study of risk factors for pulmonary embolism in women","volume":"277","author":"Goldhaber","year":"1997","journal-title":"JAMA"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/2\/347\/1055614\/zpe00211000347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/2\/347\/1055614\/zpe00211000347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T14:36:34Z","timestamp":1685889394000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/2\/347\/65177\/Hormonal-Contraception-and-Thrombotic-Risk-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":96,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,1]]},"published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-2221","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}